All the information you need about RECORDATI ORPHAN DRUGS to develop and secure your business in France

| Deposit | Confidentiality | closing date | document |
|---|---|---|---|
| 2023-06-22 | Public | 2022-12-31 | Complete |
| 2022-05-31 | Public | 2021-12-31 | Complete |
| 2021-05-31 | Public | 2020-12-31 | Complete |
| 2020-06-19 | Public | 2019-12-31 | Complete |
| 2019-05-21 | Public | 2018-12-31 | Complete |
| 2018-06-13 | Public | 2017-12-31 | Complete |
| 2017-05-29 | Public | 2016-12-31 | Complete |
| Name | RECORDATI ORPHAN DRUGS |
| Siren | 501282743 |
| Closing | 2016-12-31 |
| Registry code | 9201 |
| Registration number | 18599 |
| Management number | 2007B07971 |
| Activity code | 6420Z |
| Closing date n-1 | 2015-12-31 |
| Duration Fiscal year | 12 |
| Duration Fiscal year n-1 | 00 |
| Filing date | 2017-05-29 |
| Modification | 01 Annual accounts entered with accounting inconsistencies at document source |
| Balance sheet type | C : Complete |
| Currency code | EUR |
| Confidentiality | Public |
| Address | 92800 PUTEAUX |
| 1 - Assets (balance sheet) | Gross amount year N | Amortization year N | Net year N | Net year N-1 |
BH Other financial assets | 123 006 229.00 | 123 006 229.00 | 123 006 229.00 | |
BJ TOTAL (I) | 134 439 528.00 | 1 281 916.00 | 133 157 611.00 | 134 439 528.00 |
BX Customers and related accounts | 30 793.00 | 30 793.00 | 30 793.00 | |
CF Cash and cash equivalents | 4 458.00 | 4 458.00 | 4 458.00 | |
CJ TOTAL (II) | 45 971 793.00 | 45 971 793.00 | 45 971 793.00 | |
CO Grand total (0 to V) | 180 411 384.00 | 1 281 916.00 | 179 129 467.00 | 180 411 384.00 |
| 2 - Liabilities (balance sheet) | Amount year N | Amount year N-1 | ||
230 Other income | 3.00 | 3.00 | 3.00 | |
232 Total operating income excluding VAT | 2 012 631.00 | 1 974 555.00 | 2 012 631.00 | |
234 Purchases of goods (including customs duties) | -807 301.00 | -779 213.00 | -807 301.00 | |
244 Taxes, duties and similar payments | -82 457.00 | -64 800.00 | -82 457.00 | |
262 Other expenses | -1.00 | |||
264 Total operating expenses | -1 016 422.00 | -970 679.00 | -1 016 422.00 | |
270 Operating profit | 996 208.00 | 1 003 875.00 | 996 208.00 | |
306 Income tax's | 612 600.00 | 1 134 319.00 | 612 600.00 | |
310 Profit or loss | 6 091 901.00 | 8 722 516.00 | 6 091 901.00 | |
DA Share or individual capital | 57 000 000.00 | 57 000 000.00 | 57 000 000.00 | |
DB Share, merger, contribution premiums, etc. | 3 978 958.00 | 3 978 958.00 | 3 978 958.00 | |
DD Legal reserve (1) | 2 208 128.00 | 1 772 001.00 | 2 208 128.00 | |
DG Other reserves | 19 552 690.00 | 13 952 689.00 | 19 552 690.00 | |
DH Retained earnings | 5 796 764.00 | 3 110 373.00 | 5 796 764.00 | |
DI RESULTS FOR THE YEAR (Profit or Loss) | 6 091 901.00 | 8 722 516.00 | 6 091 901.00 | |
DL TOTAL (I) | 94 628 441.00 | 88 536 539.00 | 94 628 441.00 | |
DV Miscellaneous Loans and Financial Debts (4) | 81 000 000.00 | 81 000 000.00 | 81 000 000.00 | |
DX Trade payables and related accounts | 57 133.00 | 70 529.00 | 57 133.00 | |
DY Tax and social security liabilities | 3 430 609.00 | 25 475.00 | 3 430 609.00 | |
EA Other liabilities | 844 078.00 | |||
EC TOTAL (IV) | 84 492 869.00 | 81 949 364.00 | 84 492 869.00 | |
EE Grand total (I to V) | 179 129 467.00 | 170 493 385.00 | 179 129 467.00 | |
